|
Argo Medical Technologies Ltd
wearable powered exoskeleton rewalktm Wearable Powered Exoskeleton Rewalktm, supplied by Argo Medical Technologies Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rewalktm+powered+exoskeleton/wearable+powered+exoskeleton+rewalktm/pmc11548343-278-5-9 Average 90 stars, based on 1 article reviews
wearable powered exoskeleton rewalktm - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
ReWalk Robotics Inc
powered exoskeleton rewalktm Powered Exoskeleton Rewalktm, supplied by ReWalk Robotics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rewalktm+powered+exoskeleton/robotic+exoskeleton+rewalk/pmc07957745-68-1-12 Average 90 stars, based on 1 article reviews
powered exoskeleton rewalktm - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
ReWalk Robotics Inc
rewalktm powered exoskeleton ![]() Rewalktm Powered Exoskeleton, supplied by ReWalk Robotics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/rewalktm+powered+exoskeleton/robotic+exoskeleton+rewalk/pmc04809334-123-9-2 Average 90 stars, based on 1 article reviews
rewalktm powered exoskeleton - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Journal: Medical Devices (Auckland, N.Z.)
Article Title: Clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury: systematic review with meta-analysis
doi: 10.2147/MDER.S103102
Figure Lengend Snippet: MEDLINE search strategy
Article Snippet: The ReWalkTM (
Techniques:
Journal: Medical Devices (Auckland, N.Z.)
Article Title: Clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury: systematic review with meta-analysis
doi: 10.2147/MDER.S103102
Figure Lengend Snippet: Powered exoskeleton training protocols
Article Snippet: The ReWalkTM (
Techniques:
Journal: Medical Devices (Auckland, N.Z.)
Article Title: Clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury: systematic review with meta-analysis
doi: 10.2147/MDER.S103102
Figure Lengend Snippet: Ability to ambulate using a powered exoskeleton without physical assistance. Notes: Data represent the proportion of subjects who were able to ambulate using an exoskeleton without physical assistance at the end of the training period. Fixed effects estimates: 76.2% (95% CI: 66.7%–84.1%); random effects estimates: 76.2% (95% CI: 58.6%–90.1%); I 2 =73%, P <0.001. Abbreviation: CI, confidence interval.
Article Snippet: The ReWalkTM (
Techniques:
Journal: Medical Devices (Auckland, N.Z.)
Article Title: Clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury: systematic review with meta-analysis
doi: 10.2147/MDER.S103102
Figure Lengend Snippet: Outcomes of randomized controlled trial comparing powered exoskeleton, reciprocating gait orthosis, and hip-knee-ankle-foot orthosis. Notes: A is PCI, B is 6-min walk distance, and C is walking velocity. *Exoskeleton outcomes superior to RGO and HKAFO for walking velocity (both P <0.001), 6-minute walk distance ( P =0.03 vs RGO; P <0.01 vs HKAFO), and PCI (both P <0.001). Abbreviations: HKAFO, hip-knee-ankle-foot orthosis; PCI, physiological cost index; RGO, reciprocating gait orthosis.
Article Snippet: The ReWalkTM (
Techniques:
Journal: Medical Devices (Auckland, N.Z.)
Article Title: Clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury: systematic review with meta-analysis
doi: 10.2147/MDER.S103102
Figure Lengend Snippet: Six-minute walk test results with a powered exoskeleton. Notes: Data represent the number of meters walked with exoskeleton at the end of the training period. Fixed effects estimates: 99 m (95% CI: 92–106 m); random effects estimates: 98 m (95% CI: 80–117 m); I 2 =85%, P <0.001. Abbreviation: CI, confidence interval.
Article Snippet: The ReWalkTM (
Techniques:
Journal: Medical Devices (Auckland, N.Z.)
Article Title: Clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury: systematic review with meta-analysis
doi: 10.2147/MDER.S103102
Figure Lengend Snippet: Metabolic equivalents with powered exoskeleton walking. Notes: Data represent the number of metabolic equivalents (METs) required for exoskeleton walking at the end of the training period. METs were calculated as 1 MET per 2.7 mL O 2 /kg based on the estimated or measured maximal aerobic capacity values, unless otherwise specified. Fixed effects estimates: 3.9 METs (95% CI: 3.8, 4.0 METs); random effects estimates: 3.3 METs (95% CI: 2.2, 4.4 METs); I 2 =98%, P <0.001. Abbreviation: CI, confidence interval.
Article Snippet: The ReWalkTM (
Techniques:
Journal: Medical Devices (Auckland, N.Z.)
Article Title: Clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury: systematic review with meta-analysis
doi: 10.2147/MDER.S103102
Figure Lengend Snippet: Rating of perceived exertion with powered exoskeleton walking. Notes: Data represent subjective rating of perceived exertion (RPE; Borg 6–20 scale) required for exoskeleton walking at the end of the training period. Fixed and random effects estimates: 10.1 (95% CI: 9.0, 11.3); I 2 =0%, P =0.97. Abbreviations: CI, confidence interval; RPE, rating of perceived exertion.
Article Snippet: The ReWalkTM (
Techniques:
Journal: Medical Devices (Auckland, N.Z.)
Article Title: Clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury: systematic review with meta-analysis
doi: 10.2147/MDER.S103102
Figure Lengend Snippet: Spasticity decreases with powered exoskeleton training. Notes: Data represent the proportion of subjects who reported decreases in spasticity with exoskeleton training. Fixed effects estimates: 36.7% (95% CI: 21.9%, 53.6%); random effects estimates: 37.7% (95% CI: 18.5%, 59.2%); I 2 =46%, P =0.12. Abbreviation: CI, confidence interval.
Article Snippet: The ReWalkTM (
Techniques:
Journal: Medical Devices (Auckland, N.Z.)
Article Title: Clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury: systematic review with meta-analysis
doi: 10.2147/MDER.S103102
Figure Lengend Snippet: Improvements in bowel movement regularity with powered exoskeleton training. Notes: Data represent the proportion of subjects who reported improvements in bowel movement regularity with exoskeleton training. Fixed effects estimates: 57.7% (95% CI: 37.3%, 76.3%); random effects estimates: 60.9% (95% CI: 19.5%, 94.5%); I 2 =81%, P <0.01. Abbreviation: CI, confidence interval.
Article Snippet: The ReWalkTM (
Techniques:
Journal: Medical Devices (Auckland, N.Z.)
Article Title: Clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury: systematic review with meta-analysis
doi: 10.2147/MDER.S103102
Figure Lengend Snippet: Incidence of falls with a powered exoskeleton. Notes: Data represent the proportion of subjects who experienced a fall at any point during the training period. Fixed effects estimates: 4.3% (95% CI: 1.1%, 10.8%); random effects estimates: 4.4% (95% CI: 1.0%, 10.0%); I 2 =11%, P =0.34. Abbreviation: CI, confidence interval.
Article Snippet: The ReWalkTM (
Techniques:
Journal: Medical Devices (Auckland, N.Z.)
Article Title: Clinical effectiveness and safety of powered exoskeleton-assisted walking in patients with spinal cord injury: systematic review with meta-analysis
doi: 10.2147/MDER.S103102
Figure Lengend Snippet: Incidence of fractures with a powered exoskeleton. Notes: Data represent the proportion of subjects who experienced a bone fracture at any point during the training period. Fixed effects estimates: 3.4% (95% CI: 0.7%, 9.5%); random effects estimates: 3.4% (95% CI: 0.7%, 8.1%); I 2 =0%, P =0.98. Abbreviation: CI, confidence interval.
Article Snippet: The ReWalkTM (
Techniques: